miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1

Background: The breast epithelial cells in patients with triple-negative breast cancer (TNBC) actually have specific estrogen receptor (ER) expression, and the abnormal glycosylation of UGT1A1 in TNBC cells resulted in abnormal expression and function of ERα through regulating the modification of ER...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Zhou, Yidong, Mao, Feng, Shen, Songjie, Zhao, Bin, Xu, Yali, Lin, Yan, Zhang, Xiaohui, Cao, Xi, Xu, Ying, Chen, Chang, Zhang, Jinqian, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479224/
https://www.ncbi.nlm.nih.gov/pubmed/32983995
http://dx.doi.org/10.3389/fonc.2020.01509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479224/
https://www.ncbi.nlm.nih.gov/pubmed/32983995
http://dx.doi.org/10.3389/fonc.2020.01509

Ejemplares similares